A detailed history of Rhumbline Advisers transactions in National Research Corp stock. As of the latest transaction made, Rhumbline Advisers holds 21,623 shares of NRC stock, worth $424,675. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,623
Previous 21,453 0.79%
Holding current value
$424,675
Previous $492,000 0.41%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$20.61 - $26.17 $3,503 - $4,448
170 Added 0.79%
21,623 $494,000
Q2 2024

Aug 01, 2024

BUY
$22.95 - $39.34 $20,471 - $35,091
892 Added 4.34%
21,453 $492,000
Q1 2024

May 09, 2024

BUY
$36.87 - $41.2 $16,849 - $18,828
457 Added 2.27%
20,561 $814,000
Q4 2023

Feb 08, 2024

BUY
$39.05 - $46.39 $17,845 - $21,200
457 Added 2.33%
20,104 $795,000
Q3 2023

Nov 09, 2023

BUY
$41.8 - $46.78 $13,208 - $14,782
316 Added 1.63%
19,647 $871,000
Q2 2023

Aug 08, 2023

BUY
$40.78 - $46.7 $11,092 - $12,702
272 Added 1.43%
19,331 $841,000
Q1 2023

May 11, 2023

BUY
$38.17 - $47.17 $47,941 - $59,245
1,256 Added 7.05%
19,059 $829,000
Q4 2022

Feb 14, 2023

BUY
$35.23 - $41.21 $5,460 - $6,387
155 Added 0.88%
17,803 $664,000
Q3 2022

Nov 10, 2022

BUY
$33.58 - $40.66 $39,960 - $48,385
1,190 Added 7.23%
17,648 $702,000
Q2 2022

Aug 11, 2022

BUY
$31.87 - $40.9 $69,253 - $88,875
2,173 Added 15.21%
16,458 $630,000
Q1 2022

May 12, 2022

BUY
$36.33 - $42.25 $980 - $1,140
27 Added 0.19%
14,285 $566,000
Q4 2021

Feb 10, 2022

SELL
$40.05 - $49.0 $9,772 - $11,956
-244 Reduced 1.68%
14,258 $592,000
Q3 2021

Nov 12, 2021

BUY
$42.17 - $54.5 $18,343 - $23,707
435 Added 3.09%
14,502 $612,000
Q2 2021

Aug 05, 2021

SELL
$43.54 - $51.55 $44,889 - $53,148
-1,031 Reduced 6.83%
14,067 $646,000
Q1 2021

May 06, 2021

SELL
$42.92 - $54.13 $49,529 - $62,466
-1,154 Reduced 7.1%
15,098 $707,000
Q4 2020

Feb 10, 2021

BUY
$42.75 - $58.98 $38,047 - $52,492
890 Added 5.79%
16,252 $695,000
Q3 2020

Nov 12, 2020

SELL
$46.51 - $59.98 $103,112 - $132,975
-2,217 Reduced 12.61%
15,362 $756,000
Q2 2020

Aug 13, 2020

BUY
$42.29 - $59.2 $90,246 - $126,332
2,134 Added 13.82%
17,579 $1.02 Million
Q1 2020

May 06, 2020

BUY
$35.01 - $70.35 $2,835 - $5,698
81 Added 0.53%
15,445 $702,000
Q4 2019

Feb 05, 2020

BUY
$55.77 - $67.47 $18,682 - $22,602
335 Added 2.23%
15,364 $1.01 Million
Q3 2019

Oct 23, 2019

BUY
$55.58 - $67.42 $15,006 - $18,203
270 Added 1.83%
15,029 $868,000
Q2 2019

Aug 14, 2019

BUY
$38.52 - $57.59 $34,860 - $52,118
905 Added 6.53%
14,759 $850,000
Q1 2019

May 01, 2019

SELL
$37.2 - $40.0 $17,260 - $18,560
-464 Reduced 3.24%
13,854 $535,000
Q4 2018

Jan 31, 2019

BUY
$36.2 - $40.0 $175,533 - $193,960
4,849 Added 51.21%
14,318 $546,000
Q3 2018

Nov 07, 2018

SELL
$35.8 - $40.0 $23,269 - $26,000
-650 Reduced 6.42%
9,469 $366,000
Q2 2018

Aug 06, 2018

BUY
$28.45 - $38.35 $43,955 - $59,250
1,545 Added 18.02%
10,119 $378,000
Q1 2018

May 02, 2018

SELL
$28.3 - $38.45 $8,490 - $11,535
-300 Reduced 3.38%
8,574 $251,000
Q4 2017

Feb 09, 2018

SELL
$31.4 - $38.55 $54,730 - $67,192
-1,743 Reduced 16.42%
8,874 $331,000
Q3 2017

Nov 06, 2017

BUY
$29.4 - $37.9 $312,139 - $402,384
10,617
10,617 $400,000

Others Institutions Holding NRC

About NATIONAL RESEARCH CORP


  • Ticker NRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 24,767,100
  • Market Cap $486M
  • Description
  • National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-re...
More about NRC
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.